Related Experiment Videos
[Placental lactogen (HPL) in amniotic fluid]
Bollettino Della Societa Italiana Di Biologia Sperimentale
|April 15, 1980
Summary
Human placental lactogen (HPL) in amniotic fluid aids in assessing fetal erythroblastosis. Measuring HPL may also help manage diabetic pregnancies.
Area of Science:
- Reproductive endocrinology
- Maternal-fetal medicine
- Biochemical diagnostics
Context:
- Analysis of human placental lactogen (HPL) in amniotic fluid.
- Evaluation of fetal well-being during pregnancy.
- Investigating potential diagnostic markers in obstetric complications.
Purpose:
- To assess the utility of amniotic fluid HPL levels in evaluating fetal erythroblastosis.
- To explore the potential role of HPL measurements in managing pregnancies complicated by diabetes.
Summary:
- Human placental lactogen (HPL) was quantified in 52 amniotic fluid samples.
- Amniotic fluid HPL assays show promise for assessing fetal erythroblastosis severity.
- Further research may establish HPL measurement in amniotic fluid for managing maternal diabetes.
Impact:
- Provides a potential new biomarker for fetal distress in erythroblastosis.
- Suggests a novel approach for monitoring diabetic pregnancies.
- Enhances understanding of HPL's role in feto-maternal health.